Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revlimid Dose Finding in Biochemically Relapsed Prostate Cancer
NCT00348595Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Jul 2006
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in prostate cancer (PCa), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Jul 2006; status: completed.
02
Drugs
lenalidomide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00348595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00348595.